Reaction
Application Site Erosion reporting signals
As of the last recalculation, Application Site Erosion appears in 1,275 FAERS reports alongside 11 co-occurring drug terms. The strongest observed disproportionality signal is BUPRENORPHINE (PRR 37.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Buprenorphine | 184 | 37.8 | 37.8 |
| Methylphenidate | 60 | 35.5 | 35.5 |
| Glycerin, Lidocaine | 13 | 15.3 | 15.3 |
| Docosanol | 13 | 14.6 | 14.6 |
| Nicotine | 35 | 14.5 | 14.5 |
| Fentanyl Citrate | 15 | 13.9 | 13.9 |
| Estradiol | 62 | 12.3 | 12.3 |
| Oxybutynin | 20 | 11.3 | 11.3 |
| Minoxidil | 17 | 6.2 | 6.2 |
| Nicotine Polacrilex | 14 | 6.0 | 6.0 |
| Minoxidil Foam 5% (Womens) | 9 | 4.5 | 4.5 |